Scarica l'app Stockscreener
4.35
2.11%
0.09
Dopo l'orario di chiusura:
4.39
0.04
+0.92%
Cytomx Therapeutics Inc Azioni (CTMX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
63.36%
18.66
|
50.92 | 25.11 | 33.43 |
Operating Expenses
|
29.52%
19.94
|
28.30 | 33.57 | 29.32 |
| Benefits Costs and Expenses |
31.40%
18.75
|
27.33 | 31.60 | 27.64 |
| Costs And Expenses |
31.40%
18.75
|
27.33 | 31.60 | 27.64 |
| Operating Income/Loss |
105.68%
-1.286
|
22.62 | -8.452 | 4.111 |
| Income/Loss From Continuing Operations Before Tax |
100.39%
-0.091
|
23.59 | -6.483 | 5.797 |
| Income Tax Expense/Benefit |
1.61%
0.063
|
0.062 | 0.051 | 0.061 |
| Income/Loss From Continuing Operations After Tax |
100.65%
-0.154
|
23.52 | -6.534 | 5.736 |
|
Net Income/Loss
|
100.65%
-0.154
|
23.52 | -6.534 | 5.736 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - |
| Basic Average Shares |
48.16%
129.08
|
87.12 | 84.88 | 85.09 |
| Diluted Average Shares |
48.11%
129.08
|
87.15 | 84.88 | 85.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):